FdaApplication

BLA 761354

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBiogen MA Inc.
application_typeBLA
approval_date2023-09-29

Products (3)

ProductActive ingredientStrengthDosage form
TOFIDENCETOCILIZUMAB-BAVI400MG/20ML (20MG/ML)Injection
TOFIDENCETOCILIZUMAB-BAVI200MG/10ML (20MG/ML)Injection
TOFIDENCETOCILIZUMAB-BAVI80MG/4ML (20MG/ML)Injection

3 products